Details
About Us
Triomics partners with cancer care providers to develop tailored Generative AI applications that empower different stakeholders with deep insights and productivity boosts to enhance workflows and decision making. Our technology helps the care and research teams make use of their health record datasets to eliminate the painstaking process of retrieving, summarizing or synthesizing information and insights for various functions.
Our Gen AI powered platform, which leverages our proprietary oncology-focused large language model (OncoLLM) developed in conjunction with several leading cancer centers, eliminates the operational inefficiencies in trial recruitment, data curation for reporting and other laborious tasks involved in clinical research and care.